13,14-dihydro-15-keto-tetranor Prostaglandin F1α – 25 µg

Brand:
Cayman
CAS:
24379-94-0
Storage:
-20
UN-No:
De Minimis - 1170 / 3

The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω carbon produces the abundant urinary metabolites, including tetranor-PGFM.{2128,2129,2130,2131} 13,14-dihydro-15-keto tetranor PGF1α is a potential metabolite of either PGF1α or PGF2α and likely precursor to tetranor-PGFM.  

 

SKU: - Category:

Description

A potential metabolite of either PGF1α or PGF2α and likely precursor to tetranor-PGFM


Formal name: 9α,11α-dihydroxy-15-oxo-2,3,4,5-tetranor prostanoic acid

Synonyms: 

Molecular weight: 300.4

CAS: 24379-94-0

Purity: ≥98%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway